Long‐Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta‐Analysis
Journal of Viral Hepatitis · 2025-02 · 32 (2)
DOI: 10.1111/jvh.70003 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 20.01.2025. Verfasst von Hannah Ramrakhiani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Hepatitis B Vaccines, Hepatitis B, Hepatitis B Antibodies, Immunologic Memory. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Brown University.
Abstract (Originalsprache)
Using a systematic review and meta‐analytic approach, this study determined the durability of HBV immunity and the prevalence of anamnestic response to a booster HBV vaccine dose in individuals previously vaccinated with a 3‐dose HBV vaccine series as children or adolescents. Two researchers independently searched PubMed, Embase and Cochrane from inception to 6/1/2023 and performed data extraction. Studies that included individuals with significant comorbidities or < 5 years of follow‐up were excluded. Of 2517 potential studies, we analysed 91 eligible studies (193,359 individuals from 208 cohorts [some studies provided data for more than one cohort]). Median age at vaccination was 0 years (range: 0–20.00). After a median follow‐up of 10.15 years (range: 5–35), 63.2% (95% CI: 59.3–67.0) retained HBV immunity. HBV immunity declined by 6.62% per follow‐up year (Ptrend < 0.0001). In meta‐regression adjusting for vaccine type, follow‐up time and geographic location, age at vaccination was significantly associated with retaining HBV immunity (adjusted odds ratio [aOR] 1.12 per year, p < 0.0001). Anamnestic response rate (44 studies, 66 cohorts, 29,040 patients) was 90.34% (95% CI: 86.84–92.98), with highest rates in Europe and Asia, but only study setting (clinical versus community‐based: aOR 2.21, p = 0.034) was an independent factor. HBV immunity prevalence was about 60% after 10 years following childhood vaccination. Anamnestic response rate was about 90% and varied by study setting. Testing for immunity should be considered in individuals with high exposure risk and distant vaccination history with booster as needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA.
- Brown University, Providence, Rhode Island, USA.
- Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
- Loma Linda School of Medicine, Loma Linda, California, USA.
- Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- Stanford University, Palo Alto, California, USA.
ORCID-Profile: Yee Hui Yeo, Mindie H Nguyen
Förderung
- Brown University
Zitieren
APA
Ramrakhiani, H., Le, M. H., Kam, L., Nguyen, B., Yeo, Y. H., Levesley, C. R., Gudapati, S., Barnett, S., Cheung, R., & Nguyen, M. H. (2025). Long‐Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta‐Analysis. Journal of Viral Hepatitis, 32(2). https://doi.org/10.1111/jvh.70003
Vancouver
Ramrakhiani H, Le MH, Kam L, Nguyen B, Yeo YH, Levesley CR, et al. Long‐Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta‐Analysis. Journal of Viral Hepatitis. 2025;32(2). doi:10.1111/jvh.70003
BibTeX
@article{Ramrakhiani2025,
author = {Ramrakhiani, Hannah and Le, Michael H and Kam, Leslie and Nguyen, Brian and Yeo, Yee Hui and Levesley, Charles R and Gudapati, Surya and Barnett, Scott and Cheung, Ramsey and Nguyen, Mindie H},
title = {Long‐Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta‐Analysis},
journal = {Journal of Viral Hepatitis},
year = {2025},
volume = {32},
number = {2},
doi = {10.1111/jvh.70003}
}
EUVIMED